On September 27, 2019, SVTC + Constellar Ventures hosted its third annual Silicon Valley Science and Technology Forum at the venerable Computer History Museum in Mountain View, CA. Seventeen Silicon Valley-based veterans from the field of biomedical technology were invited as speakers to discuss the impact of new technologies on the healthcare industry.
Following the second panel discussion: HealthTech + BioPharma, the conference dived into its third panel to start drill down into the various topics of Healthcare. Third panel began with the topic “Healthtech + VC” moderated by Lise Feng (Founder of LF Consultancy and a contributor to Forbes and Trive Global), Frank Caufield (Managing Director of Darwin Ventures), Calvin Chin (Managing Director of E14 Fund), and Alex Kolicich (Founding Partner of 8VC) as panelists.
From left to right: Lise Feng, Frank Caufield, Calvin Chin, Alex Kolicich
Key takeaways from this panel:
“I look at AI as a tool, like any other tool and good company will have a variety of tools on their tool belt.”
- Frank Caufield, Managing Director, Darwin Ventures
“AI not only needs to improve the "doctor experience", but also needs to be able to help in the financial end, patient confidence in medical decisions, and medical choice recommendations, which means that the development of AI in the health field also needs to consider how to improve experience.”
- Calvin Chin, Managing Director, E14 Fund
“It comes along the backdrop of probably being the best private market fundraising environment in 15 years in every industry. So it's not just Healthtech, it's we see incredible interest in investing in SaaS, Healthcare, BioTech, Consumer. Literally everything.”
- Alex Kolicich, Founding Partner, 8VC
This year’s forum was full of lively dialogue and insightful discussions, many of which, unfortunately, cannot be conveyed here. We will continue publishing articles summarizing and analyzing topics from the forum, as well as reports from other relevant forums from time to time. If you are interested, we invite you to follow us on our social media.